CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Novel lubricant Miami w/ fragrance +4 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02309294
NCT02309294N/ACompleted

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin

Church & Dwight Company, Inc.·interventional·Posted Dec 5, 2014·Updated Oct 12, 2016

In Brief

A clinical study evaluating Novel lubricant Miami w/ fragrance, Novel lubricant Miami no fragrance, and 3 other interventions for Cumulative Irritation. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The objective of this study is to determine the ability of the study material to cause irritation to the skin of humans under controlled patch test conditions. Substances that come into contact with human skin need to be evaluated for their propensity to irritate and/or sensitize. This testing is a modified primary irritancy patch test that can detect weak irritants that require multiple applications to cause a skin reaction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 5, 2014
Enrollment StartDec 1, 2014
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 11.6 years ago

Interventions

Novel lubricant Miami w/ fragrancedevice

0.2 ml aliquot on occlusive patch

Novel lubricant Miami no fragrancedevice

0.2 ml aliquot on occlusive patch

KY Liquid lubricantdevice

0.2 ml aliquot on occlusive patch

Astroglide Gel lubricantdevice

0.2 ml aliquot on occlusive patch

Wet Platinum lubricantdevice

0.2 ml aliquot on occlusive patch